{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T04:56:09Z","timestamp":1791262569734,"version":"4.1.0"},"reference-count":57,"publisher":"Oxford University Press (OUP)","issue":"16","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,8,15]]},"DOI":"10.1093\/hmg\/ddr229","type":"journal-article","created":{"date-parts":[[2011,5,26]],"date-time":"2011-05-26T21:10:43Z","timestamp":1306444243000},"page":"3278-3288","source":"Crossref","is-referenced-by-count":122,"title":["RAD51C is a susceptibility gene for ovarian cancer"],"prefix":"10.1093","volume":"20","author":[{"given":"Liisa M.","family":"Pelttari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tuomas","family":"Heikkinen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Kallioniemi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johanna","family":"Schleutker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaija","family":"Holli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carl","family":"Blomqvist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristiina","family":"Aittom\u00e4ki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralf","family":"B\u00fctzow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heli","family":"Nevanlinna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2011,5,25]]},"reference":[{"key":"key\n\t\t\t\t20170522133823_DDR229C1","doi-asserted-by":"crossref","first-page":"74","DOI":"10.3322\/canjclin.55.2.74","article-title":"Global cancer statistics, 2002","volume":"55","author":"Parkin","year":"2005","journal-title":"CA Cancer J. Clin."},{"key":"key\n\t\t\t\t20170522133823_DDR229C2","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1016\/S0140-6736(01)06524-2","article-title":"Familial breast cancer: Collaborative reanalysis of individual data from 52 epidemiological studies including 58,209 women with breast cancer and 101,986 women without the disease","volume":"358","author":"Collaborative Group on Hormonal Factors in Breast Cancer","year":"2001","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20170522133823_DDR229C3","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/sj.bjc.6600008","article-title":"A comprehensive model for familial breast cancer incorporating BRCA1, BRCA2 and other genes","volume":"86","author":"Antoniou","year":"2002","journal-title":"Br. J. Cancer"},{"key":"key\n\t\t\t\t20170522133823_DDR229C4","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/ng853","article-title":"Polygenic susceptibility to breast cancer and implications for prevention","volume":"31","author":"Pharoah","year":"2002","journal-title":"Nat. Genet."},{"key":"key\n\t\t\t\t20170522133823_DDR229C5","doi-asserted-by":"crossref","first-page":"5898","DOI":"10.1038\/sj.onc.1209879","article-title":"Models of genetic susceptibility to breast cancer","volume":"25","author":"Antoniou","year":"2006","journal-title":"Oncogene"},{"key":"key\n\t\t\t\t20170522133823_DDR229C6","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1126\/science.7545954","article-title":"A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1","volume":"266","author":"Miki","year":"1994","journal-title":"Science"},{"key":"key\n\t\t\t\t20170522133823_DDR229C7","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1038\/378789a0","article-title":"Identification of the breast cancer susceptibility gene BRCA2","volume":"378","author":"Wooster","year":"1995","journal-title":"Nature"},{"key":"key\n\t\t\t\t20170522133823_DDR229C8","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1126\/science.1978757","article-title":"Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms","volume":"250","author":"Malkin","year":"1990","journal-title":"Science"},{"key":"key\n\t\t\t\t20170522133823_DDR229C9","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/ng0597-64","article-title":"Germline mutations of the PTEN gene in cowden disease, an inherited breast and thyroid cancer syndrome","volume":"16","author":"Liaw","year":"1997","journal-title":"Nat. Genet."},{"key":"key\n\t\t\t\t20170522133823_DDR229C10","doi-asserted-by":"crossref","first-page":"896","DOI":"10.7326\/0003-4819-128-11-199806010-00004","article-title":"Increased risk for cancer in patients with the peutz-jeghers syndrome","volume":"128","author":"Boardman","year":"1998","journal-title":"Ann. Intern. Med."},{"key":"key\n\t\t\t\t20170522133823_DDR229C11","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1002\/1097-0142(19930201)71:3<677::AID-CNCR2820710305>3.0.CO;2-#","article-title":"Extracolonic cancer in hereditary nonpolyposis colorectal cancer","volume":"71","author":"Watson","year":"1993","journal-title":"Cancer"},{"key":"key\n\t\t\t\t20170522133823_DDR229C12","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1093\/jnci\/dji141","article-title":"Cancer risks and mortality in heterozygous ATM mutation carriers","volume":"97","author":"Thompson","year":"2005","journal-title":"J. Natl Cancer Inst."},{"key":"key\n\t\t\t\t20170522133823_DDR229C13","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/ng879","article-title":"Low-penetrance susceptibility to breast cancer due to CHEK2(*)1100delC in noncarriers of BRCA1 or BRCA2 mutations","volume":"31","author":"Meijers-Heijboer","year":"2002","journal-title":"Nat. Genet."},{"key":"key\n\t\t\t\t20170522133823_DDR229C14","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1038\/ng1959","article-title":"PALB2, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility gene","volume":"39","author":"Rahman","year":"2007","journal-title":"Nat. Genet."},{"key":"key\n\t\t\t\t20170522133823_DDR229C15","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1038\/ng1902","article-title":"Truncating mutations in the fanconi anemia J gene BRIP1 are low-penetrance breast cancer susceptibility alleles","volume":"38","author":"Seal","year":"2006","journal-title":"Nat. Genet."},{"key":"key\n\t\t\t\t20170522133823_DDR229C16","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1002\/humu.20599","article-title":"Contribution of BRCA1 and BRCA2 mutations to inherited ovarian cancer","volume":"28","author":"Ramus","year":"2007","journal-title":"Hum. Mutat."},{"key":"key\n\t\t\t\t20170522133823_DDR229C17","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1038\/nature05887","article-title":"Genome-wide association study identifies novel breast cancer susceptibility loci","volume":"447","author":"Easton","year":"2007","journal-title":"Nature"},{"key":"key\n\t\t\t\t20170522133823_DDR229C18","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1038\/ng2064","article-title":"Common variants on chromosomes 2q35 and 16q12 confer susceptibility to estrogen receptor-positive breast cancer","volume":"39","author":"Stacey","year":"2007","journal-title":"Nat. Genet."},{"key":"key\n\t\t\t\t20170522133823_DDR229C19","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1038\/ng.131","article-title":"Common variants on chromosome 5p12 confer susceptibility to estrogen receptor-positive breast cancer","volume":"40","author":"Stacey","year":"2008","journal-title":"Nat. Genet."},{"key":"key\n\t\t\t\t20170522133823_DDR229C20","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1038\/ng.318","article-title":"Genome-wide association study identifies a new breast cancer susceptibility locus at 6q25.1","volume":"41","author":"Zheng","year":"2009","journal-title":"Nat. Genet."},{"key":"key\n\t\t\t\t20170522133823_DDR229C21","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/ng.354","article-title":"Newly discovered breast cancer susceptibility loci on 3p24 and 17q23.2","volume":"41","author":"Ahmed","year":"2009","journal-title":"Nat. Genet."},{"key":"key\n\t\t\t\t20170522133823_DDR229C22","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1038\/ng.424","article-title":"A genome-wide association study identifies a new ovarian cancer susceptibility locus on 9p22.2","volume":"41","author":"Song","year":"2009","journal-title":"Nat. Genet."},{"key":"key\n\t\t\t\t20170522133823_DDR229C23","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1038\/ng.666","article-title":"Common variants at 19p13 are associated with susceptibility to ovarian cancer","volume":"42","author":"Bolton","year":"2010","journal-title":"Nat. Genet."},{"key":"key\n\t\t\t\t20170522133823_DDR229C24","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1038\/ng.668","article-title":"A genome-wide association study identifies susceptibility loci for ovarian cancer at 2q31 and 8q24","volume":"42","author":"Goode","year":"2010","journal-title":"Nat. Genet."},{"key":"key\n\t\t\t\t20170522133823_DDR229C25","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1056\/NEJMra0809889","article-title":"Susceptibility pathways in fanconi's anemia and breast cancer","volume":"362","author":"D'Andrea","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"key\n\t\t\t\t20170522133823_DDR229C26","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1126\/science.1073834","article-title":"Biallelic inactivation of BRCA2 in fanconi anemia","volume":"297","author":"Howlett","year":"2002","journal-title":"Science"},{"key":"key\n\t\t\t\t20170522133823_DDR229C27","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1038\/ng1625","article-title":"The DNA helicase BRIP1 is defective in fanconi anemia complementation group J","volume":"37","author":"Levitus","year":"2005","journal-title":"Nat. Genet."},{"key":"key\n\t\t\t\t20170522133823_DDR229C28","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1038\/ng1624","article-title":"The BRCA1-interacting helicase BRIP1 is deficient in fanconi anemia","volume":"37","author":"Levran","year":"2005","journal-title":"Nat. Genet."},{"key":"key\n\t\t\t\t20170522133823_DDR229C29","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/ng1947","article-title":"Biallelic mutations in PALB2 cause fanconi anemia subtype FA-N and predispose to childhood cancer","volume":"39","author":"Reid","year":"2007","journal-title":"Nat. Genet."},{"key":"key\n\t\t\t\t20170522133823_DDR229C30","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/ng1942","article-title":"Fanconi anemia is associated with a defect in the BRCA2 partner PALB2","volume":"39","author":"Xia","year":"2007","journal-title":"Nat. Genet."},{"key":"key\n\t\t\t\t20170522133823_DDR229C31","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S1097-2765(01)00173-3","article-title":"Interaction of the fanconi anemia proteins and BRCA1 in a common pathway","volume":"7","author":"Garcia-Higuera","year":"2001","journal-title":"Mol. Cell"},{"key":"key\n\t\t\t\t20170522133823_DDR229C32","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1038\/ng.570","article-title":"Mutation of the RAD51C gene in a fanconi anemia-like disorder","volume":"42","author":"Vaz","year":"2010","journal-title":"Nat. Genet."},{"key":"key\n\t\t\t\t20170522133823_DDR229C33","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1038\/ng.569","article-title":"Germline mutations in breast and ovarian cancer pedigrees establish RAD51C as a human cancer susceptibility gene","volume":"42","author":"Meindl","year":"2010","journal-title":"Nat. Genet."},{"key":"key\n\t\t\t\t20170522133823_DDR229C34","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1093\/nar\/26.5.1179","article-title":"Isolation and characterization of RAD51C, a new human member of the RAD51 family of related genes","volume":"26","author":"Dosanjh","year":"1998","journal-title":"Nucleic Acids Res."},{"key":"key\n\t\t\t\t20170522133823_DDR229C35","doi-asserted-by":"crossref","first-page":"2858","DOI":"10.1128\/MCB.21.8.2858-2866.2001","article-title":"Chromosome instability and defective recombinational repair in knockout mutants of the five Rad51 paralogs","volume":"21","author":"Takata","year":"2001","journal-title":"Mol. Cell Biol."},{"key":"key\n\t\t\t\t20170522133823_DDR229C36","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1083\/jcb.200811079","article-title":"RAD51C facilitates checkpoint signaling by promoting CHK2 phosphorylation","volume":"185","author":"Badie","year":"2009","journal-title":"J. Cell Biol."},{"key":"key\n\t\t\t\t20170522133823_DDR229C37","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1126\/science.1171202","article-title":"Exomic sequencing identifies PALB2 as a pancreatic cancer susceptibility gene","volume":"324","author":"Jones","year":"2009","journal-title":"Science"},{"key":"key\n\t\t\t\t20170522133823_DDR229C38","doi-asserted-by":"crossref","first-page":"3214","DOI":"10.1158\/1078-0432.CCR-08-3128","article-title":"The breast cancer susceptibility mutation PALB2 1592delT is associated with an aggressive tumor phenotype","volume":"15","author":"Heikkinen","year":"2009","journal-title":"Clin. Cancer Res."},{"key":"key\n\t\t\t\t20170522133823_DDR229C39","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1038\/sj.ejhg.5200529","article-title":"Multiple founder effects and geographical clustering of BRCA1 and BRCA2 families in finland","volume":"8","author":"Sarantaus","year":"2000","journal-title":"Eur. J. Hum. Genet."},{"key":"key\n\t\t\t\t20170522133823_DDR229C40","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1093\/oxfordjournals.aje.a008964","article-title":"Borderline ovarian tumors in finland: Epidemiology and familial occurrence","volume":"144","author":"Auranen","year":"1996","journal-title":"Am. J. Epidemiol."},{"key":"key\n\t\t\t\t20170522133823_DDR229C41","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.molonc.2009.01.004","article-title":"Intercepting pelvic cancer in the distal fallopian tube: Theories and realities","volume":"3","author":"Crum","year":"2009","journal-title":"Mol. Oncol."},{"key":"key\n\t\t\t\t20170522133823_DDR229C42","doi-asserted-by":"crossref","DOI":"10.1007\/s10549-011-1543-x","article-title":"A HRM-based screening method detects RAD51C germ-line deleterious mutations in spanish breast and ovarian cancer families","author":"Romero","year":"2011","journal-title":"Breast Cancer Res. Treat."},{"key":"key\n\t\t\t\t20170522133823_DDR229C43","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1007\/s10549-010-1095-5","article-title":"Screening RAD51C nucleotide alterations in patients with a family history of breast and ovarian cancer","volume":"124","author":"Zheng","year":"2010","journal-title":"Breast Cancer Res. Treat."},{"key":"key\n\t\t\t\t20170522133823_DDR229C44","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1186\/bcr2619","article-title":"RAD51C germline mutations in breast and ovarian cancer patients","volume":"12","author":"Akbari","year":"2010","journal-title":"Breast Cancer Res."},{"key":"key\n\t\t\t\t20170522133823_DDR229C45","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1186\/bcr2823","article-title":"Mutation screening of RAD51C in male breast cancer patients","volume":"13","author":"Silvestri","year":"2011","journal-title":"Breast Cancer Res."},{"key":"key\n\t\t\t\t20170522133823_DDR229C46","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1093\/hmg\/8.10.1913","article-title":"Molecular genetics of the finnish disease heritage","volume":"8","author":"Peltonen","year":"1999","journal-title":"Hum. Mol. Genet."},{"key":"key\n\t\t\t\t20170522133823_DDR229C47","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1034\/j.1399-0004.2002.610401.x","article-title":"Genetics of population isolates","volume":"61","author":"Arcos-Burgos","year":"2002","journal-title":"Clin. Genet."},{"key":"key\n\t\t\t\t20170522133823_DDR229C48","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/ng1096-185","article-title":"Ashkenazi jewish population frequencies for common mutations in BRCA1 and BRCA2","volume":"14","author":"Roa","year":"1996","journal-title":"Nat. Genet."},{"key":"key\n\t\t\t\t20170522133823_DDR229C49","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/ng0596-117","article-title":"A single BRCA2 mutation in male and female breast cancer families from iceland with varied cancer phenotypes","volume":"13","author":"Thorlacius","year":"1996","journal-title":"Nat. Genet."},{"key":"key\n\t\t\t\t20170522133823_DDR229C50","first-page":"1242","article-title":"Analysis of BRCA1 and BRCA2 mutations in hungarian families with breast or breast-ovarian cancer","volume":"60","author":"Ramus","year":"1997","journal-title":"Am. J. Hum. Genet."},{"key":"key\n\t\t\t\t20170522133823_DDR229C51","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1002\/(SICI)1097-0215(20000601)86:5<737::AID-IJC21>3.0.CO;2-1","article-title":"Prevalence of founder BRCA1 and BRCA2 mutations among breast and ovarian cancer patients in hungary","volume":"86","author":"Van Der Looij","year":"2000","journal-title":"Int. J. Cancer"},{"key":"key\n\t\t\t\t20170522133823_DDR229C52","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1038\/nature05609","article-title":"A recurrent mutation in PALB2 in finnish cancer families","volume":"446","author":"Erkko","year":"2007","journal-title":"Nature"},{"key":"key\n\t\t\t\t20170522133823_DDR229C53","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1086\/341943","article-title":"A CHEK2 genetic variant contributing to a substantial fraction of familial breast cancer","volume":"71","author":"Vahteristo","year":"2002","journal-title":"Am. J. Hum. Genet."},{"key":"key\n\t\t\t\t20170522133823_DDR229C54","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S1535-6108(03)00110-7","article-title":"Chk1 and Chk2 kinases in checkpoint control and cancer","volume":"3","author":"Bartek","year":"2003","journal-title":"Cancer Cell"},{"key":"key\n\t\t\t\t20170522133823_DDR229C55","doi-asserted-by":"crossref","first-page":"4667","DOI":"10.1158\/1078-0432.CCR-08-0210","article-title":"Penetrance analysis of the PALB2 c.1592delT founder mutation","volume":"14","author":"Erkko","year":"2008","journal-title":"Clin. Cancer Res."},{"key":"key\n\t\t\t\t20170522133823_DDR229C56","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1086\/421251","article-title":"CHEK2*1100delC and susceptibility to breast cancer: A collaborative analysis involving 10,860 breast cancer cases and 9,065 controls from 10 studies","volume":"74","author":"CHEK2 Breast Cancer Case-Control Consortium","year":"2004","journal-title":"Am. J. Hum. Genet."},{"key":"key\n\t\t\t\t20170522133823_DDR229C57","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1093\/jnci\/92.18.1529","article-title":"Population-based study of BRCA1 and BRCA2 mutations in 1035 unselected finnish breast cancer patients","volume":"92","author":"Syrjakoski","year":"2000","journal-title":"J. Natl Cancer Inst."}],"container-title":["Human Molecular Genetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/hmg\/article-pdf\/20\/16\/3278\/17252337\/ddr229.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,8,23]],"date-time":"2017-08-23T03:55:47Z","timestamp":1503460547000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/hmg\/article-lookup\/doi\/10.1093\/hmg\/ddr229"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,5,25]]},"references-count":57,"journal-issue":{"issue":"16","published-online":{"date-parts":[[2011,5,25]]},"published-print":{"date-parts":[[2011,8,15]]}},"URL":"https:\/\/doi.org\/10.1093\/hmg\/ddr229","relation":{},"ISSN":["1460-2083","0964-6906"],"issn-type":[{"value":"1460-2083","type":"electronic"},{"value":"0964-6906","type":"print"}],"subject":[],"published":{"date-parts":[[2011,5,25]]}}}